Article

Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension

2023-09-28

Abstract excerpt

<title>Abstract</title> <p>About one-third of patients with depression do not achieve adequate response to current treatment options. Although intravenous and intranasal administrations of (es)ketamine have shown antidepressant properties, their accessibility and scalability are limited. We investigated the efficacy, safety, and tolerability of generic oral esketamine in patients with treatment-resistant depressi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 30f4f330-6fb3-59ec-97c3-15ece099b215
DOI: 10.21203/rs.3.rs-3373293/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extensionDOI 10.21203/rs.3.rs-3373293/v1Read

Ketamine in severe, highly treatment-resistant depression—a retrospective case study and a perspectiveSemantic proximity Read

Ketamine as an adjunctive therapy for major depression - a randomised controlled pragmatic pilot trial (Karma-Dep Trial)Semantic proximity Read

Real-world patient characteristics, treatment patterns, efficacy and safety of intramuscular ketamine treatment: a retrospective cohort studySemantic proximity Read

A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Trial to Verify the Efficacy and Safety of Ansofaxine (LY03005) for Major Depressive DisorderSemantic proximity Read

Propofol for treatment resistant depression: A randomized controlled trialSemantic proximity Read

Tolerability and Efficacy of Vortioxetine Versus SSRIs in Elderly With Major Depression. Study Protocol of the VESPA Study: A Pragmatic, Multicentre, Open-Label, Parallel-Group, Superiority, Randomized TrialSemantic proximity Read

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.Semantic proximity Read

Sublingual Ketamine for Depression and Anxiety: A Retrospective Study of Real-World Clinical OutcomesSemantic proximity Read

Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study.Semantic proximity Read

The role of cytochrome P450 polymorphisms in the pharmacokinetics of oral esketamine.Semantic proximity Read

Treatment-resistant depression: molecular mechanisms and managementSemantic proximity Read

Ketamine Reimagined: Distinguishing Psychedelic and Psycholytic Modalities for Next-Generation Therapies.Semantic proximity Read